Irinotecan Ebewe 20 mg/ml concetrate for solution for infusion
Land: Bulgarien
Sprache: Bulgarisch
Quelle: Изпълнителна агенция по лекарствата
Gebrauchsinformation
(PIL)
12-08-2019
Fachinformation
(SPC)
12-08-2019
Verfügbar ab:
Ebewe Pharma Ges.m.b.H. Nfg.KG
ATC-Code:
L01XX19
Dosierung:
20 mg/ml concetrate for solution for infusion
Produktbesonderheiten:
Irinotecan Ebewe, 20 mg/ml concentrate for solution for infusion 40 mg/2ml, 100mg/5ml, 150mg/7.5ml(1 vial,5 vials,10 vials); 300 mg/15ml, 500mg/25ml -1 vial
Berechtigungsdatum:
2015-01-27
